The most commonly reported side effects of GLP-1 therapy include nausea, vomiting, constipation, diarrhea, bloating, burping, and dizziness
By adopting healthy lifestyle changes, the goal is that youll be able to reduce the dose and the dosing frequency of your GLP-1 agonist
Third, for researchers who are comparing protocols between different peptides, the injection site considerations discussed here apply equally to retatrutide vs
Improvements in glycaemic control 6 months after treatment initiation were sustained at 12 months, whereas maximum weight loss benefits required at least 12 months to become apparent
Step 5: Adjust injection timing